Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Aug 19, 2020
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Purchase
Common stock, $0.0001 par value
2020-08-19$2.50/sh+2,000$5,000→ 16,377 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.